Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-01-14 @ 4:35 PM
Study NCT ID:
NCT00075868
Status:
COMPLETED
Last Update Posted:
2015-11-17
First Post:
2004-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Sponsor:
Radiation Therapy Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | radiation enteritis | View |
| None | drug/agent toxicity by tissue/organ | View |
| None | stage I rectal cancer | View |
| None | stage II rectal cancer | View |
| None | stage III rectal cancer | View |
| None | stage IIIA anal cancer | View |
| None | stage IIIB anal cancer | View |
| None | recurrent anal cancer | View |
| None | stage I anal cancer | View |
| None | stage II anal cancer | View |
| None | recurrent rectal cancer | View |